INTINI, Francesco Paolo
 Distribuzione geografica
Continente #
NA - Nord America 5.392
AS - Asia 2.031
EU - Europa 1.938
SA - Sud America 519
AF - Africa 77
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.960
Nazione #
US - Stati Uniti d'America 5.338
RU - Federazione Russa 807
SG - Singapore 806
CN - Cina 600
BR - Brasile 412
SE - Svezia 334
HK - Hong Kong 247
UA - Ucraina 153
IT - Italia 143
DE - Germania 131
FI - Finlandia 127
VN - Vietnam 98
FR - Francia 94
IN - India 77
GB - Regno Unito 62
BD - Bangladesh 30
AR - Argentina 28
CA - Canada 23
IQ - Iraq 23
TR - Turchia 21
CO - Colombia 20
ZA - Sudafrica 20
CI - Costa d'Avorio 18
MX - Messico 17
BE - Belgio 16
SA - Arabia Saudita 16
PK - Pakistan 15
ID - Indonesia 14
IE - Irlanda 14
VE - Venezuela 14
EC - Ecuador 13
PL - Polonia 13
MA - Marocco 11
CL - Cile 10
IR - Iran 10
KE - Kenya 10
PH - Filippine 10
CZ - Repubblica Ceca 9
ES - Italia 9
JP - Giappone 9
PY - Paraguay 9
UZ - Uzbekistan 8
JO - Giordania 7
AT - Austria 6
MY - Malesia 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
UY - Uruguay 5
AZ - Azerbaigian 4
BO - Bolivia 4
ET - Etiopia 4
KZ - Kazakistan 4
NL - Olanda 4
PE - Perù 4
DZ - Algeria 3
IL - Israele 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
AL - Albania 2
BH - Bahrain 2
CR - Costa Rica 2
EG - Egitto 2
HR - Croazia 2
KG - Kirghizistan 2
NP - Nepal 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
DM - Dominica 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
ZW - Zimbabwe 1
Totale 9.960
Città #
Fairfield 696
Woodbridge 460
Ashburn 443
Chandler 440
Singapore 403
Jacksonville 314
Houston 289
Seattle 283
Nyköping 276
San Jose 260
Hong Kong 244
Cambridge 236
Wilmington 210
Ann Arbor 156
Beijing 131
Nanjing 128
New York 106
Lawrence 92
Roxbury 92
Boardman 87
Lauterbourg 80
Princeton 70
Des Moines 63
Bari 60
Los Angeles 54
Nanchang 51
Helsinki 47
Ho Chi Minh City 41
Brooklyn 39
Inglewood 39
São Paulo 39
Dallas 30
San Diego 28
Santa Clara 28
Jiaxing 26
Dearborn 25
Buffalo 24
Shenyang 24
Hanoi 22
Pune 20
Abidjan 18
Hebei 18
Rio de Janeiro 18
Munich 17
San Mateo 17
Brussels 16
Changsha 16
Tianjin 16
Council Bluffs 14
Kunming 14
Johannesburg 13
Chicago 12
Jinan 12
Leawood 12
Medellín 12
Baghdad 11
Dublin 11
Guangzhou 11
Molfetta 11
Frankfurt am Main 10
Nairobi 10
San Francisco 10
Warsaw 10
Ardabil 9
Curitiba 9
Jakarta 9
Noicattaro 9
Riyadh 9
Belo Horizonte 8
Brno 8
Corridonia 8
Denver 8
Monmouth Junction 8
Tokyo 8
Fortaleza 7
London 7
Mumbai 7
Shanghai 7
Stockholm 7
Tashkent 7
Washington 7
Amman 6
Atlanta 6
Augusta 6
Birmingham 6
Brasília 6
Chennai 6
Lanzhou 6
Toronto 6
Boston 5
Dhaka 5
Elk Grove Village 5
Mexico City 5
Montevideo 5
Montreal 5
Moscow 5
Nuremberg 5
Paris 5
Phoenix 5
Quito 5
Totale 6.710
Nome #
The First Example of a Dinuclear Platinum(III) Complex with Three Bridging Ligands 784
Anticancer potential of a photoactivated transplatin derivative containing the methylazaindole ligand mediated by ROS generation and DNA cleavage 221
Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects 191
Novel Antitumor Cisplatin and Transplatin Derivatives Containing 1‑Methyl-7-Azaindole: Synthesis, Characterization, and Cellular Responses 180
Addition of Hydroxide, Alkoxide, and Carboxylate Anions to Platinum-bonded Ethylene 157
Isomerism of amides coordinated to platinum. X-ray crystal structure of dichloro-bisacetamide-platinum(II) 153
Lantern-Shaped” Platinum(III) Complexes with Axially Bound 9-Ethylguanine or 1-Methylcytosine (L) of General Formula [Pt2{HN=C(But)O}4L2](NO3)2 145
Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl2(cis-1,4-DACH)] 136
One-Pot Synthesis of New Organometallic Compounds with Platinum-Carbon Bond 133
Cytotoxic trans-oriented platinum complexes only form adducts with single-stranded oligodeoxynucleotides 131
Cytotoxic trans-oriented iminoether platinum complexes – Kinetics of binding to DNA oligonucleotides determined by 15N NMR spectroscopy 131
Atropisomerization of cis-Bis(5'GMP)-Platinum(II)-Diamine complexes with Non-C2-symmetrical asymmetric diamine ligands containing NH groups directed to one side of the coordination plane 130
Conformer distribution in (cis-1,4-DACH)bis(guanosine5'-phosphate)platinum(II) adducts: a reliable model for DNA adducts of antitumoral cisplatin 129
NMR and X-ray characterization of a platinum(II) complex with (−)sparteine 126
Single-Stranded Oligonucleotide Adducts Formed by Pt Complexes Favoring Left-Handed Base Canting: Steric Effect of Flanking Residues and Relevance to DNA Adducts Formed by Pt Anticancer Drugs 124
A novel head-to-head conformer of d(GpG) cross-linked by Pt: New light on the conformation of such cross-links formed by Pt anticancer drugs 124
Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine 121
Bis[iodo(N,N,N′,N'',N''-pentamethyldiethyl-enetriamine- kappa N-3)platinum(II)] di-μ-iodobis[diiodoplatinate(II)] 120
Insights into the Molecular Mechanisms of Protein Platination from a Case Study: The Reaction of Anticancer Platinum(II) Iminoethers with Horse Heart Cytochrome c 120
Dependence of the Reduction Products of Platinum(IV) Prodrugs upon the Configuration of the Substrate, Bulk of the Carrier Ligands, and Nature of the Reducing Agent 120
Potentiation of cytotoxic action of cis-[PtCl2(NH3)(1M7AI)] by UVA irradiation. Mechanistic insights 120
NMR and X-ray Structural Characterization of a Cisplatin Analogue Able To Slow Down the Pt−N7 Rotation of a Coordinated Guanine Base by a Billion-Fold Times: 2,2'-Bipiperidine(dimethylmalonato)platinum(II) Complex 119
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 119
Influence of carrier ligand NH hydrogen bonding to the O6 and phosphate group of Guanine nucleotides in Platinum complexes with a single guanine ligand 118
ANTIBACTERIAL AND ANTICANCER ACTIVITY OF PLATINUM COMPLEXES WITH CHIRAL DIAMINES 117
Platinum amides from platinum nitriles: X-ray crystal structure of trans-dichloro-bis(1-imino-1-hydroxy-2,2-dimethylpropane)platinum(II) 117
Synthesis and structural characterization of isomeric "lantern-shaped" platinum(III) complexes of formula [Pt2(PPh3)X{N(H)C(R)O}4](NO3)2 (X=PPh3, H2O) 113
Chirality-Controlling Chelate (CCC) Ligands in Analogs of Platinum Anticancer Agents. Influence of N9 Substituents of Guanine Derivatives (G) on the Distribution of Chiral Conformers of (CCC)PtG2 with CCC = N,N'-Dimethyl-2,3-diaminobutane 113
Unusual reactivity at a platinum center determined by the ligands and the solvent environment 111
Biological Activity of Platinum Complexes Containing Chiral Centers on the Nitrogen or Carbon atoms of a Chelate Diamine Ring. Inorg. Chim. Acta, 110
Solution Behavior of Amidine Complexes: An Unexpected cis/trans Isomerization and Formation of Di- and Trinuclear Platinum(III) and Platinum(II) Species 107
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 106
Cisplatin and zoledronic acid: two drugs combined in a Pt(II) complex with potential antitumor activity towards bone tumors and metastases 104
null 104
Synthesis and X-ray crystal structure of a trans-dichloro(1-cyano-2,2-dimethylpropane)(1-imino-1-hydroxy-2,2-dimethylpropane)platinum(II) 100
Solvolysis of Platinum Complexes with Substituted Ethylenediamines in Dimethylsulfoxide 99
Factors Influencing the Configuration and Conformation of Diamine Chelate Rings in Platinum(II) Compounds: 2,4- Bis(methylamino)pentane Complexes 99
trans-Chloridobis[(Z)-1-imino-1-methoxyethane-N](triphenylphosphane-P)platinum(II) chloride monohydrate 99
New steric hindrance approach employing the hybrid ligand 2-aminomethylpiperidine for diminishing dynamic motion problems of platinum anticancer drug adducts containing guanine derivatives 97
Isolation, Characterization, and Kinetics of Formation of the cis and trans Isomers of Bis(acetonitrile)dichloroplatinum(II) 97
Energetics, conformation, and recognition of DNA duplexes modified by methylated analogues of [PtCl(dien)]+ 96
Effects of six-membered-ring conformation on the rotamer distribution and rate of atropisomerization in platinum(II)-guanine compounds: 2,4-bis(methylamino)pentane complexes 96
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 94
Synthesis and spectroscopic and structural characterization of different configurations of the tridentate amine ligand N,N’,N’’-trimethyldiethylenetriamine coordinated to platinum 93
Synthesis, characterization, and biological activity of platinum II, III, and IV pivaloamidine complexes 93
Structural characterization of the “lantern-shaped” platinum(III) complex [Pt2Cl2{N(H)C(But)O}4] 92
A trans-platinum complex showing higher antitumor activity than the cis congeners 92
Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration 90
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 90
null 89
Complessi antitumorali di platino a geometria trans 89
null 88
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 88
Cyclodextrin polymers as carriers for the platinum-based anticancer agent LA-12 88
Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts of Guanine Derivatives with the Hybrid Ligand Approach: Evidence for Cis Interligand Interactions Especially between 3'-GMP's 86
Retro-Models of Pt Anticancer Drug DNA Adducts: Chirality-Controlling Chelate (CCC) Ligand Restriction of Guanine Dynamic Motion in (2,2'-Bipiperidine)PtG2 Complexes (G = Guanine Derivative) 85
DIFFERENT BINDING TO DNA OF ENANTIOMERIC PLATINUM COMPLEXES ASSESSED BY INHIBITION OF RESTRICTION ENZYME-ACTIVITY 84
Platinum(II) complexes with the purine derivatives Penciclovir and Famciclovir; monoadducts with potential antitumor and antiviral activity 83
IRREVERSIBLE ADDITION OF CARBON NUCLEOPHILES TO ETHYLENE IN CATIONIC PLATINUM(II) COMPLEXES 83
Synthesis and Crystal Structure of a Trans-Diaquabis(amidato) Complex of Platinum(II) 82
Sinthesis and stereochemical characterisation of platinum(II) complexes with the antiviral agents penciclovir and famciclovir 81
Synthesis and X-Ray Structural Characterization of the First Unbridged Diplatinum(III) Compound: Bis[bis(1-imino-1-hydroxy-2,2-dimethyl-propane)-trichloroplatinum(III)] 81
Stereochemical Investigations of Cationic Olefin Complexes of Platinum(II) Containing Chiral Diamines: a Sequence of Four Asymmetric Centres (N, C, C and N) in the chelate ring 80
null 80
X-ray Structural Characterization of the Bis-Guanine Derivative of a Cisplatin Analogue Having Just One Proton on Each Coordinated Nitrogen and a Head-to-Head Conformation: [Pt{(±)-N,N'-dimethylbutane-2,3-diamine}(9-ethyl-guanine)2]dinitrate 78
Biochemical aspects of antitumor effects of a new platinum(IV) drug 78
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 77
NUCLEOPHILIC-ATTACK OF METHANOL ON BIS(BENZONITRILE)DICHLOROPLATINUM - FORMATION OF MONO-IMIDO AND BIS-IMIDO ESTER DERIVATIVES 77
A new generation of platinum anticancer complexes with trans geometry 73
Sinthesis and characterisation of the amidine complexes trans-[PtCl(NH3)(HN=C(NH2)R)2]Cl (R= Me,Ph,CH2Ph) derived from addition of NH3 to the coordinated nitriles in trans-[PtCl2(NCR)2] 72
Retro-modeling in Pt anticancer drug chemistry 70
X-ray Structure of the first Platinum Complexes with Z Configuration of the Iminoether Ligands: trans Dichlorobis(1-imino-1-methoxy- 2,2'-dimethylpropane)platinum(II) and trans-Tetrachlorobis(1-imino-1-methoxy-2,2'-dimethylpropane)platinum(IV) 70
Isomerism of amides coordinated to platinum - X-ray crystal structure of O-bonded acetamide in a platinum(II) complex 68
Isomerization of Platinum-Coordinated Iminoethers Induced by Spectator Ligands: Stabilization of the Z anti Configuration 67
null 67
Platinum Amides from Platinum Nitriles: X-ray Crystal Structures of the Unbridged Dinuclear Compounds Bis[bis(1-imino-1-hydroxy-2,2-dimethylpropane)dichloro-platinum(II)] and Bis[bis(1-imino-1-hydroxy-2,2-dimethylpropane)(1-amino-1-oxo-2,2-dimethylpropane)dichloro-platinum(II)] 67
DNA adducts of antitumor trans-[PtCl2(E-imimo ether)2] 66
null 66
Two polymorphs of potassium trichloro[diethyl (methylsulfinylmethyl)phosphonate-kS]platinum(II) with Z' = 1 and 3 in the space group P212121 65
In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands 64
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 62
Synthesis and Crystal Structure of the First Trinuclear Chloride-bridged Platinum(II) Complex with Mutually Perpendicular Co-ordination Planes: cyclo-Tri-mu-chloro-tris[chloro(1-hydroxy-1-imino-2,2-dimethylpropane)platinum(II)]-Dichloromethane (0.5/1) 61
null 58
Nucleophilic Attack of Amine and Hydroxide to Platinum Dibenzonitrile Dichloride. Crystal structure of [Pt(NH=CPhN-t-BuCH2CH2NH-t-Bu)Cl(NHCOPh)] (2) and cis-[Pt(NH=CPhN-t-BuCH2CH2NH-t-Bu)Cl2(NCPh)](3) 58
MECHANISTIC AND STEREOCHEMICAL INVESTIGATION OF IMINO ETHERS FORMED BY ALCOHOLYSIS OF COORDINATED NITRILES - X-RAY CRYSTAL-STRUCTURES OF CIS-BIS(1-IMINO-1-METHOXYETHANE)DICHLOROPLATINUM(II) AND TRANS-BIS(1-IMINO-1-METHOXYETHANE)DICHLOROPLATINUM(II) 56
Four- versus Five-coordination in Palladium(II) and Platinum(II) Complexes Containing 2,9-Dimethyl-1,10-phenanthroline (dmphen). Crystal Structures of [PtCl2(dmphen)] and [Pt(h2-C2H4)Cl2(dmphen)] 56
null 55
Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties 55
Synthesis and in vitro and in vivo antitumour activity of new platinum-iminoether derivatives with different configuration at the iminoether ligands 54
null 52
New platinum antitumor complexes with chiral diamines 51
Dna interaction properties of new platinum-iminoether derivatives with different configuration at the iminoether ligands 50
SYNTHESIS, MUTAGENICITY, BINDING TO PBR-322 DNA AND ANTITUMOR-ACTIVITY OF PLATINUM(II) COMPLEXES WITH ETHAMBUTOL 50
Stereochemically Controlled Ligands Influence Atropisomerization of Pt(II) Nucleotide Complexes. Evidence for Head-to-Head and Stable a Head-to-Tail Atropisomers 50
Viewing early stages of guanine nucleotide attach on Pt(II) complexes designed with in-plane bulk to trap initial adducts. Relevance to cis-Type Pt(II) anticancer drugs 50
Kinetic study of the reaction between an antitumor 15N labeled trans- platinum iminoether complex and GMP by [1H,15N] HMQC NMR 47
Synthesis and X-Ray Characterization of Two Unbridged Diplatinum(III) Compounds: cis and trans-Bis[bis(1-imino-1-methoxyethane)trichloroplatinum(III)]. Transient Species in the Oxidation of Platinum(II) to Platinum(IV) 47
Synthesis and characterization of new platinum(II) complexes with cyclic iminoether-type ligands having the azomethine group out of cycle 46
New concepts relevant to cisplatin anticancer activity from unique spectral features providing evidence that adjacent guanines in d(GpG), intrastrand-cross-linked at N7 by a cis-platinum(II) moiety, can adopt a head-to-tail arrangement 42
In vitro antitumour activity and cellular pharmacological properties of the platinum-iminoether complex trans-[PtCl2{E-HN=C(OMe)Me}2] 41
Totale 9.914
Categoria #
all - tutte 38.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.840


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021318 0 0 0 0 0 0 0 0 0 153 123 42
2021/2022675 13 95 5 31 34 39 28 42 58 61 135 134
2022/20231.209 197 101 79 112 170 166 6 148 179 14 19 18
2023/2024399 31 63 10 33 38 144 2 14 7 4 1 52
2024/20251.296 48 31 125 32 20 78 115 87 59 66 182 453
2025/20262.858 364 140 139 282 279 143 307 66 940 198 0 0
Totale 10.122